![Akateeminen Kirjakauppa](/images/index/logo-1195.jpg)
SULJE VALIKKO
KIRJAUDU
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.
Sisäänkirjautuminen
Kirjaudu sisäänRekisteröityminen |
Oma tili
Omat tiedotOmat tilaukset Omat laskut |
Lisätietoja
AsiakaspalveluTietoa verkkokaupasta Toimitusehdot Tietosuojaseloste |